论文部分内容阅读
采用选择性β１－受体激动剂多巴酚丁胺治疗充血性心衰患者８５例，治疗总有效率达８５．８８％。经常规量治疗前后血压心率变化无显著差异（Ｐ〉０．０５）。结果显示了多巴酚丁胶的短程疗法疗效好、不良反应少，尤其适于洋地黄耐受性差及顽固性心衰患者的治疗。
85 cases were treated with selective β1-agonist dobutamine in 85 patients with congestive heart failure. The total effective rate was 85.88%. There was no significant difference in blood pressure and heart rate before and after treatment (P> 0.05). The results showed that the short course of dobutamine is effective and has few adverse reactions, especially for the treatment of patients with poor digitalis and refractory heart failure.